ICU MEDICAL INC/DE - Common Stock (ICUI)

Historical Holders from Q1 2014 to Q3 2025

Symbol: ICUI on Nasdaq
Type / Class: Equity / Common Stock
Underlying class: Common Stock
Shares outstanding: 24.7M
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 25.8M
Holdings value: $3.09B
% of all portfolios: 0.003%
Grand Portfolio weight change: +0%
Number of holders: 267
Number of buys: 133
Number of sells: -143
Average Value change %: +0%
Average buys %: +0.001%
Average sells %: 0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of ICU MEDICAL INC/DE - Common Stock (ICUI)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
JANUS HENDERSON GROUP PLC	10%	0%	$326M	$272K	2.47M	+0.08%	JANUS HENDERSON GROUP PLC	30 Jun 2025

Institutional Holders of ICU MEDICAL INC/DE - Common Stock (ICUI)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	25.8M	$3.09B	+$75.8M	1.04M	1.96M	$119.96	267
2025 Q2	25.1M	$3.31B	+$97.7M	278K	4.29M	$132.15	273
2025 Q1	24.3M	$3.38B	+$22M	1.31M	15.7M	$138.86	281
2024 Q4	24.2M	$3.76B	-$58.5M	5.76M	10.5M	$155.17	285
2024 Q3	24.6M	$4.47B	+$76.9M	9.97M	9.27M	$182.22	287
2024 Q2	23.8M	$2.83B	+$149M	4.22M	3.36M	$118.75	256
2024 Q1	22.6M	$2.43B	+$116M	2.67M	1.59M	$107.32	251
2023 Q4	21.6M	$2.15B	-$89.8M	2.02M	3.62M	$99.74	241
2023 Q3	22.3M	$2.65B	-$35.1M	2.04M	2.88M	$119.01	215
2023 Q2	22.2M	$3.96B	-$74.5M	3.67M	10.9M	$178.19	227
2023 Q1	22.7M	$3.74B	+$70.5M	2.51M	8.94M	$164.96	231
2022 Q4	22.3M	$3.51B	+$39.8M	15.4M	3.09M	$157.48	241
2022 Q3	22.6M	$3.41B	-$240M	2.46M	6.01M	$150.60	231
2022 Q2	21.6M	$3.56B	+$101M	806K	4.7M	$164.39	246
2022 Q1	20.9M	$4.66B	+$151M	2.08M	11.6M	$222.64	282
2021 Q4	20.2M	$4.79B	+$34.8M	21.2M	3.94M	$237.34	288
2021 Q3	20M	$4.66B	-$54M	38.5M	20.7M	$233.38	272
2021 Q2	20.3M	$4.18B	+$50.5M	3.03M	9.57M	$205.80	266
2021 Q1	20.1M	$4.13B	+$114M	7.52M	27.3M	$205.44	277
2020 Q4	19.5M	$4.19B	+$40.7M	300K	16.3M	$214.49	273
2020 Q3	19.3M	$3.53B	-$33.1M	2.76M	12.9M	$182.76	273
2020 Q2	19.5M	$3.59B	+$747K	4.13M	34.9M	$184.31	285
2020 Q1	19.5M	$3.93B	-$44.1M	16.9M	77.2M	$201.77	264
2019 Q4	19.8M	$3.7B	+$109M	7.22M	16.1M	$187.12	262
2019 Q3	19.2M	$3.06B	-$169M	4.64M	21.4M	$159.60	246
2019 Q2	19.5M	$4.91B	+$236M	9.47M	29.5M	$251.91	266
2019 Q1	18.7M	$4.49B	-$83.3M	13.7M	18.2M	$239.33	285
2018 Q4	19M	$4.37B	+$710M	4.09M	9.09M	$229.63	286
2018 Q3	15.7M	$4.44B	+$195M	16.1M	32.3M	$282.75	344
2018 Q2	15.1M	$4.42B	+$58.9M	14.8M	31.4M	$293.65	339
2018 Q1	14.9M	$3.75B	-$171M	2.73M	5.12M	$252.40	286
2017 Q4	15.6M	$3.36B	-$74.4M	10.5M	6.93M	$216.00	254
2017 Q3	15.9M	$2.95B	+$34.2M	4.37M	632K	$185.85	224
2017 Q2	15.7M	$2.71B	+$285M	449K	2.5M	$172.50	225
2017 Q1	15.5M	$2.37B	+$305M	643K	1.53M	$152.70	229
2016 Q4	15.2M	$2.24B	+$104M	957K	987K	$147.35	243
2016 Q3	14.5M	$1.83B	+$26M	2.19M	1.26M	$126.38	226
2016 Q2	14.3M	$1.62B	-$1.97M	462K	1.24M	$112.75	215
2016 Q1	14.4M	$1.5B	+$37.5M	4.14M	4.19M	$104.10	211
2015 Q4	14.1M	$1.59B	-$25.8M	394K	542K	$112.78	223
2015 Q3	14.3M	$1.56B	-$33.6M	1.88M	1.15M	$109.50	205
2015 Q2	14.7M	$1.4B	+$22.3M	2.16M	3.41M	$95.66	194
2015 Q1	14.5M	$1.35B	+$33.5M		438K	$93.14	185
2014 Q4	14.2M	$1.16B	+$12.7M	0	442K	$81.90	192
2014 Q3	14.3M	$918M	-$3.36M	366K	250K	$64.18	171
2014 Q2	14.4M	$873M	+$5.45M	237K	328K	$60.81	161
2014 Q1	14.3M	$855M	+$41.9M	533K	509K	$59.88	166